Related Experiment Video
Updated: Jul 20, 2026
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
Development and Validation of a Cytochrome C Oxidase Subunit 6B2-Based Risk Model for Cholangiocarcinoma Recurrence
Meiru Chen1,2, Xiaoli Xie1, Jiaqi Wang1
1Department of Gastroenterology, Hebei Key Laboratory of Gastroenterology, The Second Hospital of Hebei Medical University, Hebei Institute of Gastroenterology, Hebei Clinical Research Center for Digestive Diseases, Shijiazhuang, China.
Cytochrome C oxidase subunit 6B2 (COX6B2) shows promise as a biomarker for predicting cholangiocarcinoma recurrence. A composite model integrating COX6B2 with clinicopathologic features enhances risk stratification for personalized patient management.
Area of Science:
- Oncology
- Biomarker Discovery
- Molecular Diagnostics
Background:
- Cholangiocarcinoma (CCA) has high recurrence rates and poor prognosis.
- Predictive biomarkers are crucial for personalized treatment planning in CCA.
Purpose of the Study:
- Evaluate Cytochrome C oxidase subunit 6B2 (COX6B2) as a biomarker for CCA recurrence.
- Develop a composite risk model for CCA recurrence prediction.
Main Methods:
- Transcriptomic screening identified COX6B2 as a recurrence-associated gene.
- Immunohistochemistry validated COX6B2 protein levels in training and validation cohorts.
- A composite model integrated COX6B2 with clinicopathologic variables.
Main Results:
- COX6B2 was significantly upregulated in recurrent CCA.
- COX6B2 demonstrated strong predictive performance (AUC 0.81-0.87).
- The composite model achieved superior accuracy (AUC 0.93) and stratified patients effectively.
Conclusions:
- COX6B2 is a potential tissue-based biomarker for CCA recurrence.
- The composite model offers a practical approach for risk assessment and management.
- Individualized postoperative management can be improved using this model.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025